Supplementary Tables 1 - 9 from Primate-Specific Mir-663 Functions As a Tumor Suppressor by Targeting PIK3CD and Predicts the Prognosis of Human Glioblastoma

Yu Shi,Cong Chen,Xia Zhang,Qing Liu,Jin-Ling Xu,Hua-Rong Zhang,Xiao-Hong Yao,Tao Jiang,Zhi-Cheng He,Yong Ren,Wei Cui,Chuan Xu,Ling Liu,You-Hong Cui,Shi-Zhu Yu,Yi-Fang Ping,Xiu-Wu Bian
DOI: https://doi.org/10.1158/1078-0432.22452554
2023-01-01
Abstract:PDF file - 169K, Supplementary Table S1. The clinical features of the glioma specimens used in this study. Supplementary Table S2. Primers used for qRT-PCT, miRNA cloning and luciferase plasmid construction. Supplementary Table S3. Top 20 downregulated miRNAs in tumor tissue (GBM-T) versus adjacent normal tissue (GBM-N). Supplementary Table S4. Top 20 upregulated miRNAs in tumor tissue (GBM-T) versus adjacent normal tissue (GBM-N). Supplementary Table S5. The correlation between miR-663 expression and clinicopathological factors of patients with astrocytoma (Grade I and II). Supplementary Table S6. The correlation between miR-663 expression and clinicopathological factors of patients with anaplastic astrocytoma (Grade III). Supplementary Table S7. The correlation between miR-663 expression and clinicopathological factors of patients with GBM (Grade IV). Supplementary Table S8. Univariate analysis for disease-free survival and overall survival in GBM patients. Supplementary Table S9. Top 30 overlapped predicted targets of miR-663 and their degrees based on signal transduction network.
What problem does this paper attempt to address?